"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about HEPARIN
• Ask Community about HEPARIN
• HEPARIN Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

HEPARIN Safety Questions, HEPARIN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about HEPARIN. Our extensive database of HEPARIN adverse events and HEPARIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about HEPARIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

HEPARIN Safety Reports

Total HEPARIN reports: 259.
HEPARIN FDA safety alerts: 2002 2005 2006 2007 .
Reported deaths: 40    Reported hospitalizations: 122.
Take HEPARIN Side Effects Survey or Share Your HEPARIN Story. HEPARIN Usage.

< Previous  Showing 151-225 of 259 Next >

Pharmacist from UNITED STATES reported HEPARIN problem on Aug 23, 2006. Male patient, 82 years of age, weighting 148.8 lb, was diagnosed with dialysis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac tamponade, hypersplenism, laboratory test abnormal, pericardial effusion, platelet count decreased, shock, transfusion reaction, venous pressure increased. HEPARIN dosage: 5000 UNIT/ML 1.8 ML ORT. During the same period patient was treated with CEFAZOLIN, INSULIN, COMBIVENT, XALATAN, METOPROLOL TARTRATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Aug 23, 2006. Male patient, 64 years of age, weighting 95.00 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Aug 23, 2006. Male patient, 64 years of age, weighting 184.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: dry mouth, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2006. Male patient was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haematuria, haemoglobin decreased. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, KETOROLAC TROMETHAMINE, TRAMADOL, CLONAZEPAM, GATIFLOXACIN, SOTALOL HYDROCHLORIDE, GEMFIBROZIL, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 11, 2006. Male patient, 77 years of age, weighting 147.5 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Aug 29, 2006. Male patient, 51 years of age, was diagnosed with coronary artery bypass and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal tenderness, adrenal cortex necrosis, adrenal haemorrhage, bowel sounds abnormal, heparin-induced thrombocytopenia, hypotension, intestinal ischaemia, pyrexia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 13, 2006. Male patient was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematocrit decreased, haemoglobin decreased. HEPARIN dosage: unknown. During the same period patient was treated with ALPRAZOLAM, BUPROPION, CALCIUM ACETATE, CEFAZOLIN, FUROSEMIDE, METOCLOPRAMIDE, MORPHINE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 14, 2006. Female patient, 67 years of age, weighting 280.0 lb, was diagnosed with prophylaxis, pneumonia and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: contusion, cyanosis, oedema peripheral. HEPARIN dosage: unknown. During the same period patient was treated with CEFUROXIME, GABAPENTIN, CARTIA XT, LEVOTHROXINE, AVANDIA, GLYBURIDE, LISINOPRIL, LOVASTATIN. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 15, 2006. Male patient, 67 years of age, was diagnosed with acute coronary syndrome, acute myocardial infarction, intracardiac thrombus and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, haematuria. HEPARIN dosage: unknown. During the same period patient was treated with AL HYDROX, ASPIRIN, CLOPIDOGREL BISULPHATE. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 19, 2006. Male patient, 65 years of age, weighting 183.0 lb, was diagnosed with transient ischaemic attack, hypertension and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: rash erythematous, swelling face, swollen tongue. HEPARIN dosage: unknown. During the same period patient was treated with DIOVAN, PLAVIX, ASPIRIN, LOVASTATIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 20, 2006. Female patient, 89 years of age, weighting 187.4 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blister, cardio-respiratory arrest, ecchymosis, feeling cold, heparin-induced thrombocytopenia, intracardiac thrombus, oedema peripheral, pain in extremity, pulse absent. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, 72 years of age, weighting 220.5 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 21, 2006. Male patient, weighting 145.5 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, blood calcium decreased, blood chloride decreased, blood potassium decreased, blood sodium decreased, dysphagia, haematuria, heparin-induced thrombocytopenia test, platelet count decreased. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, weighting 200.6 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, cardiomyopathy, escherichia infection, haematocrit decreased, haemoglobin decreased, heparin-induced thrombocytopenia, ischaemic hepatitis, myocardial infarction, pneumonia staphylococcal. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 21, 2006. Male patient, 73 years of age, weighting 149.9 lb, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with REGULAR SSI WITH AMIODARONE, ATORVASTATIN, BISACODYL, CARBIDOPA, LEVODOPA, CEFEPIME, PHENYLEPHRINE, FENTANYL. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, 58 years of age, weighting 174.2 lb, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood creatine phosphokinase increased, blood creatinine increased, decubitus ulcer, deep vein thrombosis, duodenal ulcer, fall, haematochezia, rectal ulcer. HEPARIN dosage: unknown. During the same period patient was treated with CEFEPIME, METRONIDAZOLE, CHLORHEXIDINE, DOCUSATE, SENNA. Patient was hospitalized. Patient recovered.

Health Professional from AUSTRALIA reported HEPARIN problem on Sept 05, 2006. Female patient, 80 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematemesis, haemorrhage. HEPARIN dosage: unknown. Patient was hospitalized. Patient died.

HEPARIN problem was reported by a Consumer or non-health professional from AUSTRALIA on Sept 05, 2006. Female patient, 83 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematemesis, haemorrhage, melaena. HEPARIN dosage: unknown. Patient was hospitalized. Patient died.

Consumer or non-health professional from AUSTRALIA reported HEPARIN problem on Sept 05, 2006. Male patient, 80 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial. HEPARIN dosage: unknown. Patient was hospitalized. Patient died.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 22, 2006. Male patient, 50 years of age, weighting 208.8 lb, was diagnosed with pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, heparin-induced thrombocytopenia test. HEPARIN dosage: unknown. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS, PROPOFOL, PANTOPRAZOLE, ZOSYN, VANCOMYCIN, PHYTONADIONE. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 27, 2006. Female patient, 50 years of age, weighting 91.00 lb, was diagnosed with arterial bypass operation, intestinal ischaemia and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, post procedural complication. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Male patient, 49 years of age, weighting 196.2 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: catheter site haemorrhage, haematocrit decreased, haemoglobin decreased. HEPARIN dosage: unknown. During the same period patient was treated with SILDENAFIL, TERAZOSIN, NIFEDIPINE, METOPROLOL TARTRATE, INSULIN, FUROSEMIDE, COLCHICINE, ASPIRIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 20, 2006. Male patient, 89 years of age, weighting 187.4 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, blister, cardio-respiratory arrest, ecchymosis, heparin-induced thrombocytopenia, hypercoagulation, intracardiac thrombus, oedema peripheral, pain in extremity. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: overdose. HEPARIN dosage: unknown. Patient died on 09/16/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 18, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: overdose. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: overdose. HEPARIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 18, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: overdose. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: overdose. HEPARIN dosage: unknown. Patient died on 09/16/2006.

Health Professional from UNITED STATES reported HEPARIN problem on Oct 04, 2006. Male patient, 88 years of age, weighting 115.5 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: prothrombin time prolonged. HEPARIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE, NEPHROCAPS, ZOCOR, HEPARIN NA, IRON POLYSACCHARIDE, CALCIUM ACETATE. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on Oct 04, 2006. Male patient, 73 years of age, weighting 164.9 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: 100 U/ML, @8ML /HR , INTRAVEN. During the same period patient was treated with ACETAMINOPHEN, LOVENOX, MORPHINE SULPHATE, HYTRIN, AMIODARONE, METOPROLOL TARTRATE, INSULIN REG, FUROSEMIDE. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Oct 04, 2006. Male patient, 74 years of age, was diagnosed with deep vein thrombosis, pulmonary embolism and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, retroperitoneal haematoma. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Oct 04, 2006. Male patient, 70 years of age, weighting 207.2 lb, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia, pulmonary embolism. HEPARIN dosage: 10ML /HR IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 28, 2006. Male patient, weighting 4.14 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, overdose. HEPARIN dosage: 1 ML;ONCE;IV. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Male patient, weighting 2.95 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, overdose. HEPARIN dosage: 0.5 ML;ONCE;IV. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 28, 2006. Female patient, weighting 4.37 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, epistaxis, international normalised ratio increased, overdose. HEPARIN dosage: 1 ML;ONCE; IV. Patient died on 09/19/2006.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Female patient, weighting 0.90 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, international normalised ratio increased, overdose. HEPARIN dosage: 0.5 ML; ONCE;IV. Patient died on 09/16/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on Sept 28, 2006. Female patient, weighting 1.39 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder, overdose. HEPARIN dosage: 0.5 ML;ONCE;IV. Patient died on 09/16/2006.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Oct 02, 2006. Female patient was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: neonatal disorder, overdose. HEPARIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Oct 12, 2006. Male patient, 70 years of age, weighting 118.8 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Oct 17, 2006. Male patient, weighting 343.9 lb, was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. HEPARIN dosage: 25000 UNITS/ 500ML 20 ML/HOUR IV. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on Oct 17, 2006. Male patient, weighting 432.1 lb, was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: epistaxis. HEPARIN dosage: 25000 UNITS/500 ML 20ML/HR IV. During the same period patient was treated with LOVENOX. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Oct 19, 2006. Male patient, 46 years of age, weighting 160.9 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, platelet count decreased. HEPARIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on Oct 19, 2006. Male patient, 85 years of age, weighting 159.8 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with ISOSORBIDE MONONITRATE, SIMVASTATIN, NITROGLYCERIN, CLOPIDOGREL BISULPHATE, ALBUTEROL, FUROSEMIDE, OMEPRAZOLE, LISINOPRIL. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED STATES on Sept 06, 2005. Male patient, 55 years of age, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose. HEPARIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Oct 18, 2006. Male patient, 73 years of age, was diagnosed with percutaneous coronary intervention and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, electrocardiogram st segment depression, lung infiltration, pulmonary alveolar haemorrhage. HEPARIN dosage: unknown. During the same period patient was treated with EPTIFIBATIDE. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Oct 10, 2006. Male patient, 80 years of age, was diagnosed with thrombosis prophylaxis, pain and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaesthetic complication, back pain, extradural haematoma. HEPARIN dosage: 40 MG, INJECTION NOS. During the same period patient was treated with KETOROLAC, FENTANYL, BUPIVANCAINE, ROPIVACINE, MORPHINE. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Oct 26, 2006. Male patient, 57 years of age, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Oct 13, 2006. Female patient, 62 years of age, was diagnosed with ischaemia and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blood follicle stimulating hormone decreased, blood luteinising hormone decreased, diabetes insipidus, heparin-induced thrombocytopenia, hypernatraemia, ischaemia, pituitary infarction. HEPARIN dosage: unknown. During the same period patient was treated with METFORMIN, RAMIPRIL, FUROSEMIDE, ACETAMINOPHEN, TRAMADOL. Patient recovered.

Health Professional from UNITED STATES reported HEPARIN problem on Oct 10, 2006. Female patient, 44 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, incorrect dose administered, overdose. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2006. Male patient, 61 years of age, was diagnosed with thrombosis prophylaxis, cerebrovascular accident and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, gastrointestinal haemorrhage, thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with ARGATROBAN, ACETAMINOPHEN, ALBUTEROL, ASPIRIN, CALCIUM ACETATE, CASPOFUNGIN, CILASTATIN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Oct 25, 2006. Male patient, 79 years of age, was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: femoral nerve palsy, retroperitoneal haemorrhage. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Female patient, 37 years of age, was diagnosed with protein c deficiency and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, fall, femoral nerve palsy, retroperitoneal haemorrhage, sensory disturbance, soft tissue disorder, swelling. HEPARIN dosage: unknown. Patient recovered.

Physician from KOREA, REPUBLIC OF reported HEPARIN problem on Oct 26, 2006. Female patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: foetal disorder, pleural effusion, premature baby. HEPARIN dosage: unknown. Patient died.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Oct 31, 2006. Male patient, 73 years of age, weighting 221.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cyanosis, depressed level of consciousness, gangrene, heparin-induced thrombocytopenia, hepatic failure, hypoperfusion, loss of consciousness, metabolic encephalopathy, post procedural complication. HEPARIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, PAROXETINE, IPRATROPIUM BROMIDE, ALBUTEROL. Patient died on 05/10/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on Oct 31, 2006. Male patient, 68 years of age, weighting 110.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Nov 01, 2006. Female patient, 56 years of age, weighting 154.3 lb, was diagnosed with thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. HEPARIN dosage: unknown. During the same period patient was treated with LEVOPHED, PHENYTOIN, PANTOPRAZOLE, NADANSETRON, MORPHINE, METOPROLOL TARTRATE, LORAZEPAM, CEFAZOLIN. Patient died on 10/29/2006.

Pharmacist from UNITED STATES reported HEPARIN problem on Nov 01, 2006. Female patient, 64 years of age, weighting 165.3 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, anti-platelet antibody positive, heparin-induced thrombocytopenia, multi-organ failure, pulmonary embolism. HEPARIN dosage: unknown. During the same period patient was treated with HEPARIN LOCK, ASPIRIN, ADVAIR DISKUS, MORPHINE, PROTONIX, LISPRO INSULIN SLIDING SCALE, DILTIAZEM CONTINUOUS INFUSION. Patient died on 05/25/2006.

HEPARIN problem was reported by a Physician from GERMANY on Oct 25, 2006. Male patient, 61 years of age, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematoma, heparin-induced thrombocytopenia, intestinal fistula, multi-organ failure, post procedural complication, pulmonary embolism. HEPARIN dosage: unknown. Patient died.

Physician from UNITED STATES reported HEPARIN problem on Oct 24, 2006. Male patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage, incorrect dose administered. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Nov 09, 2006. Female patient, 76 years of age, weighting 97.00 lb, was diagnosed with atrial fibrillation and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haematoma. HEPARIN dosage: 25,000 UNITS/250 ML TITRATE IV. During the same period patient was treated with COUMADIN, NORVASC, DIGOXIN, ASPIRIN, NEXIUM, COREG, ALTACE, PLAVIX. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Nov 16, 2006. Male patient, 58 years of age, weighting 186.3 lb, was diagnosed with peripheral vascular disorder, prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, heparin-induced thrombocytopenia, muscle haemorrhage, transaminases increased. HEPARIN dosage: unknown. During the same period patient was treated with CYCLOSPORINE, SIROLIMUS. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Nov 16, 2006. Male patient, 58 years of age, weighting 188.1 lb, was diagnosed with prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, heparin-induced thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with AMIODARONE, ZOSYN, DILTIAZEM. Patient was hospitalized. Patient recovered.

Physician from reported HEPARIN problem on Oct 30, 2006. Male patient, 36 years of age, weighting 154.3 lb, was diagnosed with septic shock and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: 0.5 ML, DAILY (1/D). During the same period patient was treated with XIGRIS. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Nov 01, 2006. Female patient was diagnosed with coronary artery bypass, percutaneous coronary intervention and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardiac tamponade, coagulation time prolonged, coronary artery bypass, haemorrhage, suture rupture. HEPARIN dosage: unknown. During the same period patient was treated with ANGIOMAX. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Nov 01, 2006. Female patient, 62 years of age, was diagnosed with peripheral ischaemia and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: diabetes insipidus, heparin-induced thrombocytopenia, hypernatraemia, pituitary infarction. HEPARIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, DESMOPRESSIN. Patient recovered.

HEPARIN problem was reported by a Physician from UNITED STATES on Nov 10, 2006. Female patient, 36 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. HEPARIN dosage: unknown. During the same period patient was treated with OXYCODONE. Patient died on 01/01/2005.

Physician from UNITED STATES reported HEPARIN problem on Nov 10, 2006. Female patient, 82 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: adverse event. HEPARIN dosage: unknown. Patient died on 01/01/2005.

HEPARIN problem was reported by a Pharmacist from UNITED STATES on Nov 28, 2006. Male patient, 70 years of age, weighting 215.0 lb, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: 25 ML / HR. During the same period patient was treated with DIGOXIN, DILTIAZEM, FLUNISOLIDE INHALANT, FORMOTEROL, FUROSEMIDE, IPRATROPIUM BROMIDE, LEVALBUTEROL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Nov 28, 2006. Male patient, 67 years of age, weighting 216.0 lb, was diagnosed with thrombosis prophylaxis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: 5000U/0.5ML Q12. During the same period patient was treated with BISACODYL, POTASSIUM CHLORIDE, ONDANSETRON, PROTAMINE SULPHATE, MIDAZOLAM HYDROCHLORIDE, ASP SUPP. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2006. Male patient, 42 years of age, weighting 126.0 lb, was diagnosed with intravenous catheter management and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. HEPARIN dosage: unknown. During the same period patient was treated with ASPIRIN, CAL ACETATE, GEMFIBROZIL, LISINOPRIL, METOPROLOL SUCCINATE, OMEPRAZOLE, SHOLS SOLN, SIMVASTATIN. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Nov 27, 2006. Female patient, 72 years of age, weighting 152.1 lb, was diagnosed with acute coronary syndrome, coronary artery bypass and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: heparin-induced thrombocytopenia. HEPARIN dosage: unknown. Patient was hospitalized. Patient recovered.

HEPARIN problem was reported by a Health Professional from UNITED KINGDOM on Nov 17, 2006. Male patient, 58 years of age, was diagnosed with deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: axillary vein thrombosis, bronchial carcinoma, cardiac tamponade, heparin-induced thrombocytopenia, international normalised ratio increased, leukocytosis, pneumonia, skin necrosis. HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN. Patient recovered.

Pharmacist from UNITED STATES reported HEPARIN problem on Nov 14, 2006. Female patient was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. HEPARIN dosage: unknown. Patient recovered.

HEPARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Female patient, 53 years of age, was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged. HEPARIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported HEPARIN problem on Nov 15, 2006. Female patient, 86 years of age, was diagnosed with stent occlusion and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: haemorrhage. HEPARIN dosage: (USP U/ML, D), IV. During the same period patient was treated with PLAVIX, ACTIVASE, ASPIRIN. Patient was hospitalized. Patient died on 10/01/2006.

< Previous  Showing 151-225 of 259 Next >

Ask Our Patient Community about HEPARIN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed